Cancer Q&A with HOA: May is Clinical Trials Awareness Month

Cancer Q&A with HOA
May is Clinical Trials Awareness Month

Cancer Q&A with HOA: May is Clinical Trials Awareness Month

Colorectal, Pfizer C6461003

ClinicalTrials.gov ID: NCT07222800

An interventional, phase III, double-blinded, randomized study to evaluate the efficacy and safety of PF-08634404 in combination with chemotherapy versus bevacizumab in combination with chemotherapy in treatment-naïve participants with metastatic colorectal cancer.

Cancer Q&A with HOA: Esophageal Cancer with Dr. Santosh Kumar

Cancer Q&A with HOA
Esophageal Cancer with Dr. Santosh Kumar

Cancer Q&A with HOA: Esophageal Cancer with Dr. Santosh Kumar

Prostate, 20230239 “XALience”

ClinicalTrials.gov ID:  NCT07213674

A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.

Cancer Q&A with HOA: March is Multiple Myeloma Awareness Month

Cancer Q&A with HOA
March is Multiple Myeloma Awareness Month

Cancer Q&A with HOA: March is Multiple Myeloma Awareness Month

Clarity Through Second Opinions

Cancer Q&A with HOA
Receiving Clarity Through Second Opinions

Cancer Q&A with HOA: Receiving Clarity Through Second Opinions

Pages